Long-Acting Injectables Versus Oral Antipsychotics

A Retrospective Bidirectional Mirror-Image Study

Gentaro Miura, Fuminari Misawa, Yuko Kawade, Yasuo Fujii, Masaru Mimura, Taishiro Kishimoto

Research output: Contribution to journalArticle

Abstract

Purpose Mirror-image studies, which compare equal periods of time before and after a new treatment is introduced, may reflect the real-world impact of that treatment. However, most mirror-image studies that have investigated the impact of long-acting injectable antipsychotics (LAIs) were unidirectional in design, for patients switching from oral antipsychotics (OAPs) to LAIs. Therefore, we conducted a bidirectional mirror-image study comparing LAIs and OAPs. Methods We included 126 schizophrenia or schizoaffective disorder patients' LAI treatment data from 3 psychiatric hospitals. Patients took OAPs for 6 months or more before initiating LAIs, or the reverse. We obtained data on the number of hospitalizations as a primary outcome, plus the total duration and mean duration of hospitalization as secondary outcomes during the 6 months of the patients' first treatment, and the 6 months after the patients started their second type of treatment. Results The results indicated that there was no significant difference in any outcomes between LAI and OAP treatment when going from LAIs to OAPs (n = 59). However, when patients started with OAPs and switched to LAIs (n = 67), they were hospitalized a significantly fewer number of times, and the duration of their stays was shorter in the LAI phase than in the OAP phase. When combined with bidirectional data, LAI superiority was still observed. Conclusions The findings endorse the relative effectiveness of LAIs over OAPs in the real world, although the inherent flaws of mirror-image studies such as expectation bias and having no parallel comparator should be considered.

Original languageEnglish
Pages (from-to)441-445
Number of pages5
JournalJournal of clinical psychopharmacology
Volume39
Issue number5
DOIs
Publication statusPublished - 2019 Sep 1

Fingerprint

Antipsychotic Agents
Injections
Hospitalization
Therapeutics
Psychiatric Hospitals
Psychotic Disorders
Schizophrenia

Keywords

  • long-acting injectable antipsychotics
  • mirror-image study
  • oral antipsychotics
  • schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Long-Acting Injectables Versus Oral Antipsychotics : A Retrospective Bidirectional Mirror-Image Study. / Miura, Gentaro; Misawa, Fuminari; Kawade, Yuko; Fujii, Yasuo; Mimura, Masaru; Kishimoto, Taishiro.

In: Journal of clinical psychopharmacology, Vol. 39, No. 5, 01.09.2019, p. 441-445.

Research output: Contribution to journalArticle

@article{1f3330aca0ae4060aa4b00fffdb3f5b4,
title = "Long-Acting Injectables Versus Oral Antipsychotics: A Retrospective Bidirectional Mirror-Image Study",
abstract = "Purpose Mirror-image studies, which compare equal periods of time before and after a new treatment is introduced, may reflect the real-world impact of that treatment. However, most mirror-image studies that have investigated the impact of long-acting injectable antipsychotics (LAIs) were unidirectional in design, for patients switching from oral antipsychotics (OAPs) to LAIs. Therefore, we conducted a bidirectional mirror-image study comparing LAIs and OAPs. Methods We included 126 schizophrenia or schizoaffective disorder patients' LAI treatment data from 3 psychiatric hospitals. Patients took OAPs for 6 months or more before initiating LAIs, or the reverse. We obtained data on the number of hospitalizations as a primary outcome, plus the total duration and mean duration of hospitalization as secondary outcomes during the 6 months of the patients' first treatment, and the 6 months after the patients started their second type of treatment. Results The results indicated that there was no significant difference in any outcomes between LAI and OAP treatment when going from LAIs to OAPs (n = 59). However, when patients started with OAPs and switched to LAIs (n = 67), they were hospitalized a significantly fewer number of times, and the duration of their stays was shorter in the LAI phase than in the OAP phase. When combined with bidirectional data, LAI superiority was still observed. Conclusions The findings endorse the relative effectiveness of LAIs over OAPs in the real world, although the inherent flaws of mirror-image studies such as expectation bias and having no parallel comparator should be considered.",
keywords = "long-acting injectable antipsychotics, mirror-image study, oral antipsychotics, schizophrenia",
author = "Gentaro Miura and Fuminari Misawa and Yuko Kawade and Yasuo Fujii and Masaru Mimura and Taishiro Kishimoto",
year = "2019",
month = "9",
day = "1",
doi = "10.1097/JCP.0000000000001082",
language = "English",
volume = "39",
pages = "441--445",
journal = "Journal of Clinical Psychopharmacology",
issn = "0271-0749",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Long-Acting Injectables Versus Oral Antipsychotics

T2 - A Retrospective Bidirectional Mirror-Image Study

AU - Miura, Gentaro

AU - Misawa, Fuminari

AU - Kawade, Yuko

AU - Fujii, Yasuo

AU - Mimura, Masaru

AU - Kishimoto, Taishiro

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Purpose Mirror-image studies, which compare equal periods of time before and after a new treatment is introduced, may reflect the real-world impact of that treatment. However, most mirror-image studies that have investigated the impact of long-acting injectable antipsychotics (LAIs) were unidirectional in design, for patients switching from oral antipsychotics (OAPs) to LAIs. Therefore, we conducted a bidirectional mirror-image study comparing LAIs and OAPs. Methods We included 126 schizophrenia or schizoaffective disorder patients' LAI treatment data from 3 psychiatric hospitals. Patients took OAPs for 6 months or more before initiating LAIs, or the reverse. We obtained data on the number of hospitalizations as a primary outcome, plus the total duration and mean duration of hospitalization as secondary outcomes during the 6 months of the patients' first treatment, and the 6 months after the patients started their second type of treatment. Results The results indicated that there was no significant difference in any outcomes between LAI and OAP treatment when going from LAIs to OAPs (n = 59). However, when patients started with OAPs and switched to LAIs (n = 67), they were hospitalized a significantly fewer number of times, and the duration of their stays was shorter in the LAI phase than in the OAP phase. When combined with bidirectional data, LAI superiority was still observed. Conclusions The findings endorse the relative effectiveness of LAIs over OAPs in the real world, although the inherent flaws of mirror-image studies such as expectation bias and having no parallel comparator should be considered.

AB - Purpose Mirror-image studies, which compare equal periods of time before and after a new treatment is introduced, may reflect the real-world impact of that treatment. However, most mirror-image studies that have investigated the impact of long-acting injectable antipsychotics (LAIs) were unidirectional in design, for patients switching from oral antipsychotics (OAPs) to LAIs. Therefore, we conducted a bidirectional mirror-image study comparing LAIs and OAPs. Methods We included 126 schizophrenia or schizoaffective disorder patients' LAI treatment data from 3 psychiatric hospitals. Patients took OAPs for 6 months or more before initiating LAIs, or the reverse. We obtained data on the number of hospitalizations as a primary outcome, plus the total duration and mean duration of hospitalization as secondary outcomes during the 6 months of the patients' first treatment, and the 6 months after the patients started their second type of treatment. Results The results indicated that there was no significant difference in any outcomes between LAI and OAP treatment when going from LAIs to OAPs (n = 59). However, when patients started with OAPs and switched to LAIs (n = 67), they were hospitalized a significantly fewer number of times, and the duration of their stays was shorter in the LAI phase than in the OAP phase. When combined with bidirectional data, LAI superiority was still observed. Conclusions The findings endorse the relative effectiveness of LAIs over OAPs in the real world, although the inherent flaws of mirror-image studies such as expectation bias and having no parallel comparator should be considered.

KW - long-acting injectable antipsychotics

KW - mirror-image study

KW - oral antipsychotics

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=85071710210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071710210&partnerID=8YFLogxK

U2 - 10.1097/JCP.0000000000001082

DO - 10.1097/JCP.0000000000001082

M3 - Article

VL - 39

SP - 441

EP - 445

JO - Journal of Clinical Psychopharmacology

JF - Journal of Clinical Psychopharmacology

SN - 0271-0749

IS - 5

ER -